The interaction between ADAM 22 and 14-3-3ζ: Regulation of cell adhesion and spreading

Biochemical and Biophysical Research Communications

Volumn 301, Issue 4, 2003, Pages 991-999

  Zhu, Peng Cheng ^a   Sun, Yubo ^b   Xu, Rener ^a   Sang, Yingying ^a   Zhao, Jing ^a   Liu, Gang ^a   Cai, Liang ^a   Li, Changben ^a   Zhao, Shouyuan ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MEMBRANE PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; PROTEIN ADAM 22; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

EID: 0037459098     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00056-1     Document Type: Article

References (45)

1. Wrolfsberg T.G., Primakoff P., Myles D.G., White J.M. ADAM, a novel family of membrane protein containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell matrix interactions. J. Cell Biol. 131:1995;275-278.
2. Primakoff P., Myles D.G. The ADAM gene family-surface proteins with adhesion and protease activity. Trends Genet. 16:2000;83-87.
3. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature. 385:1997;729-733.
4. Blobel C.P. Metalloprotease-disintergins: links to cell adhesion and cleavage of TNF-α and notch. Cell. 90:1997;589-592.
5. Blobel C.P., Wolfsberg T.G., Truck C.W., Myles D.G., Primakoff P., White J.M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature. 356:1992;248-252.
6. Myles D.G., Kimmel L.H., Blobel C.P., White J.M., Primakoff P. Identification of a binding site in the disintegrin domain of fertilin required for sperm-egg fusion. Proc. Natl. Acad. Sci. USA. 91:1994;4195-4198.
7. Cho C., Bunch D.O., Faure J., Gouldmg E.H., Eddy E.M., Primakoff P., Myles D.G. Fertilization defects in sperm from mice lacking fertilin β Science. 281:1998;1857-1859.
8. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature. 377:1995;652-656.
9. Rooke J., Pan D., Xu T., Rubin G.M. KUZ, a conserved metalloproteinase-disintegrin protein with two roles in Drosophila neurogenesis. Science. 273:1996;1227-1231.
10. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science. 284:1999;770-776.
11. Qi H., Rand M.D., Wu X., Sestan N., Wang W., Rakic P., Xu T., Artavanis-Tsakonas Processing of the notch ligand delta by the metalloproteinase kuzbanian. Science. 283:1999;91-94.
12. Moss M.L., Jin S.L.C., Milla M.E., Burkhart W., Carter H.L., Chen W., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lamber M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schenen F., Seaton T., Su J., Warner J., Willard D., Becherer D.J. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α Nature. 385:1997;733-736.
13. Iba K., Albrechtsen R., Gilpin B.J., Loechel F., Wewer U.M. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am. J. Pathol. 154:1999;1489-1501.
14. 1 to the ADAM-12 and -15 disintegrin domain mediates cell-cell interaction J. Biol. Chem. 275:2000;34922-34930.
15. Evans J.P. Fertilin b and other ADAMs as integrin ligands: insights into cell adhesion and fertilization. BioEssays. 23:2001;628-639.
16. McCulloch D.R., Harvey M., Herington A.C. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol. Cell Endocrinol. 167:2000;11-21.
17. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., Black R.A. An essential role for ectodomain shedding in mammalian development. Science. 282:1998;1281-1284.
18. Sagane K., Yamazaki K., Mizui Y., Tanaka I. Cloning and chromosomal mapping of mouse ADAM11, ADAM22 and ADAM23. Gene. 236:1999;79-86.
19. Poindexter K., Nelson N., DuBose R.F., Black R.A., Cerretti D.P. The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries. Gene. 237:1999;61-70.
20. Aitken A., Jones D., Soneji Y., Howell S. 14-3-3 proteins: biological function and domain structure. Biochem. Soc. Trans. 23:1995;605-611.
21. Rittinger K., Budman J., Xu J., Volinia S., Cantley L.C., Smerdon S.J., Gamblin S.J., Yaffe M.B. Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell. 4:1999;153-166.
22. Morrison D. 14-3-3: modulators of signaling proteins? Science. 266:1994;56-57.
23. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 87:1996;619-628.
24. Jones D.H., Ley S., Aitken A. Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett. 368:1995;55-58.
25. Bonnefoy-Berard N., Liu Y.C., von Willebrand M., Sung A., Elly C., Mustelin T., Yoshida H., Ishizaka K., Altman A. Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc. Natl. Acad. Sci. USA. 92:1995;10142-10146.
26. Fanger G.R., Widmann C., Porter A.C., Sather S., Johnson G.L., Vaillancourt R.R. 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 273:1998;3476-3483.
27. McPherson R.A., Harding A., Roy S., Lane A., Hancock J.F. Interactions of c-Raf-1 with phosphatidylserine and 14-3-3. Oncogene. 18:1999;3862-3869.
28. Zhang L., Chen J., Fu H. Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc. Natl. Acad. Sci. USA. 96:1999;8511-8515.
29. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
30. Stavridi E.S., Chehab N.H., Malikzay A., Halazonetis T.D. Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. Cancer Res. 61:2001;7030-7033.
31. Cahill C.M., Tzivion G., Nasrin N., Ogg S., Dore J., Ruvkun G., Alexander-Bridges M. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 4-3-3-independent pathways. J. Biol. Chem. 276:2001;13402-13410.
32. Grozinger C.M., Schreiber S.L. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA. 97:2000;7835-7840.
33. Estojak J., Brent R., Golemis E.A. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15:1995;5820-5829.
34. Reuther G.W., Buss J.E., Quilham L.A., Clark G.J., Der C.J. Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences. Methods Enzymol. 327:2000;331-350.
35. Brent R., Finley R.L. Jr. Understanding gene and allele function with two hybrid method. Annu. Rev. Genet. 31:1997;663-704.
36. Sun J.J., Zhou X.D., Liu Y.K., Tang Z.Y., Sun R.X., Zhao Y., Uemura Inhibitory effects of synthetic β peptide on invasion and metastasis of liver cancer. J. Cancer Res. Clin. Oncol. 126:2000;595-600.
37. Han D.C., Rodriguez, Guan J.L. Identification of a novel interaction between integrin. β1 and 14-3-3β Oncogene. 20:2001;346-357.
38. Liu Y.C., Liu Y., Elly C., Yoshida H., Lipkowitz S., Altman A. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J. Biol. Chem. 272:1997;9979-9985.
39. Sagane K., Ohya Y., Hasegawa Y., Tanaka I. Metalloproteinase-like, cysteine-rich protein MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain. Biochem. J. 334(Part 1):1998;93-98.
40. Akiyama S.K., Yamada S.S., Yamada K.M., LaFlamme S.E. Transmembrane signal transduction by integrin cytoplasmic domains expressed in single-subunit chimeras. J. Biol. Chem. 269:1994;15961-15964.
41. Hughes P.E., Diaz-Gonzalez F., Leong L., Wu C., McDonald J.A., Shattil S.J., Ginsberg M.H. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J. Biol. Chem. 271:1996;6571-6574.
42. Cal S., Freije J.M.P., Lopez J.M., Takada Y., Lopez-Otin C. ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with avb3 integrin through an RGD-independent mechanism. Mol. Biol. Cell. 11:2000;1457-1469.
43. Hsich G., Kenney K., Gibbs C.J., Lee K.H., Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335:1996;924-930.
44. Skoulakis E.M., Davis R.L. 14-3-3 proteins in neuronal development and function. Mol. Neurobiol. 16:1998;269-284.
45. Philip N., Acevedo S.F., Skoulakis E.M. Conditional rescue of olfactory learning and memory defects in mutants of the 14-3-3zeta gene leonardo. J. Neurosci. 21:2001;8417-8425.